Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.

Biswas D, Liu YH, Herrero J, Wu Y, Moore DA, Karasaki T, Grigoriadis K, Lu WT, Veeriah S, Naceur-Lombardelli C, Magno N, Ward S, Frankell AM, Hill MS, Colliver E, de Carné Trécesson S, East P, Malhi A, Snell DM, O'Neill O, Leonce D, Mattsson J, Lindberg A, Micke P, Moldvay J, Megyesfalvi Z, Dome B, Fillinger J, Nicod J, Downward J, Szallasi Z, TRACERx Consortium, Hackshaw A, Jamal-Hanjani M, Kanu N, Birkbak NJ, Swanton C

Open source

DOI: 10.1038/s43018-024-00883-1
Published: 2025 Jan
Container: Nature cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43018-024-00883-1,
  title = {Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.},
  author = {Biswas D and Liu YH and Herrero J and Wu Y and Moore DA and Karasaki T and Grigoriadis K and Lu WT and Veeriah S and Naceur-Lombardelli C and Magno N and Ward S and Frankell AM and Hill MS and Colliver E and de Carné Trécesson S and East P and Malhi A and Snell DM and O'Neill O and Leonce D and Mattsson J and Lindberg A and Micke P and Moldvay J and Megyesfalvi Z and Dome B and Fillinger J and Nicod J and Downward J and Szallasi Z and TRACERx Consortium and Hackshaw A and Jamal-Hanjani M and Kanu N and Birkbak NJ and Swanton C},
  year = {2025},
  journal = {Nature cancer},
  doi = {10.1038/s43018-024-00883-1},
  url = {https://doi.org/10.1038/s43018-024-00883-1}
}

RIS

TY  - JOUR
TI  - Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.
AU  - Biswas D
AU  - Liu YH
AU  - Herrero J
AU  - Wu Y
AU  - Moore DA
AU  - Karasaki T
AU  - Grigoriadis K
AU  - Lu WT
AU  - Veeriah S
AU  - Naceur-Lombardelli C
AU  - Magno N
AU  - Ward S
AU  - Frankell AM
AU  - Hill MS
AU  - Colliver E
AU  - de Carné Trécesson S
AU  - East P
AU  - Malhi A
AU  - Snell DM
AU  - O'Neill O
AU  - Leonce D
AU  - Mattsson J
AU  - Lindberg A
AU  - Micke P
AU  - Moldvay J
AU  - Megyesfalvi Z
AU  - Dome B
AU  - Fillinger J
AU  - Nicod J
AU  - Downward J
AU  - Szallasi Z
AU  - TRACERx Consortium
AU  - Hackshaw A
AU  - Jamal-Hanjani M
AU  - Kanu N
AU  - Birkbak NJ
AU  - Swanton C
PY  - 2025
JO  - Nature cancer
DO  - 10.1038/s43018-024-00883-1
UR  - https://doi.org/10.1038/s43018-024-00883-1
ER  -

APA

D, B., YH, L., J, H., Y, W., DA, M., T, K., K, G., WT, L., S, V., C, N., N, M., S, W., AM, F., MS, H., E, C., S, D. C. T., P, E., A, M., DM, S., O, O., D, L., J, M., A, L., P, M., J, M., Z, M., B, D., J, F., J, N., J, D., Z, S., Consortium, T., A, H., M, J., N, K., NJ, B., & C, S. (2025). Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma.. Nature cancer. https://doi.org/10.1038/s43018-024-00883-1

Source records

pubmed · retrieved 2026-09-25T20:09:20.017Z